As explained above, we have progressed in several ways beyond state of the art. Some of the results are published already, but most are not. The most important objective in the project, which is control of content at the single molecule level, is not yet achieved, but we believe it may be possible based on the promising results so far. (For sure, nothing indicates it would not be possible.) We have also established contact with several molecular biologists to evaluate our platforms for addressing "real" biological problems. For instance, we plan to look at the oligomerization of intrinsically disordered proteins in nanoscale confinement. Here the main feature of our nanochambers compared to state of the art is that all the proteins under observation will remain confined, which extends the measurement time greatly. For comparison, using fluorescence correlation spectroscopy or conventional nanopore sensors, individual protein oligomers can only be observed, but only for about a millisecond before they diffuse away again.